Summary & Overview
HCPCS L8658: Interphalangeal Joint Spacer, Silicone or Equal
HCPCS Level II code L8658 denotes an interphalangeal joint spacer, silicone or equal, billed per device. This implantable orthopedic device is used in surgical management of interphalangeal joint disease—commonly for pain relief, stabilization, or reconstruction in finger or toe joints—and is relevant to surgeons, hospital billing teams, and payers due to device-specific coding and coverage considerations. Nationally, accurate use of L8658 affects device tracking, claims adjudication, and durable medical equipment or implant reporting.
Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise review of what the code represents, the clinical context for use, typical sites of service where the device is implanted, and which payers commonly adjudicate these claims. The publication summarizes billing considerations, common modifiers (listed separately), and contextual benchmarks where available. It also highlights areas where policy clarification or preauthorization practices commonly arise for implantable joint spacers.
This summary is intended for a national audience of clinicians, coding professionals, and policy analysts seeking a clear reference on the clinical and billing identity of HCPCS Level II code L8658. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code L8658 describes an interphalangeal joint spacer, silicone or equal, each. This supply is used as an implantable spacer in the interphalangeal joints, typically for procedures addressing joint degeneration, deformity, or pain in fingers or toes.
Service Type: Orthopedic implant / surgical implantable device
Typical Site of Service: Hospital outpatient, ambulatory surgery center, or inpatient surgical setting
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A middle-aged patient presents with pain, stiffness, and deformity of an interphalangeal joint of a finger following advanced osteoarthritis or post-traumatic joint collapse. Nonoperative measures (splinting, NSAIDs, corticosteroid injection) have failed to provide durable relief. The hand surgeon evaluates the patient in clinic, obtains radiographs showing joint space narrowing and subchondral changes, and discusses surgical options. During the operative encounter in an ambulatory surgical center or hospital outpatient department under regional or local anesthesia with sedation, the surgeon performs a limited excision and places an interphalangeal joint spacer (L8658) made of silicone to maintain joint alignment, preserve motion, and relieve pain. The device is billed as L8658 per spacer. Typical workflow includes preoperative evaluation, intraoperative placement of the silicone spacer, postoperative dressing and splinting, and short-term follow-up visits for wound check and rehabilitation with occupational therapy as needed.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier | Use when no modifier is required and billing as standard. |